Wilmington, DE -- (SBWIRE) -- 10/23/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Apple Inc. (NASDAQ:AAPL) and Gilead Sciences Inc. (NASDAQ:GILD).
Apple Inc. (NASDAQ:AAPL) a company that together with subsidiaries, designs, manufactures, and markets mobile communication and media devices, personal computing products, and portable digital music players worldwide is currently up (+0.24%) on 2,696,645 shares traded after Apple Inc. Rekindled Its Rivalry With an Old Foe. Apple Inc. (NASDAQ:AAPL) is currently up (+36.33%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Apple Inc. (NASDAQ:AAPL)
Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently up (+0.13%) on 2,226,224 shares traded after Gilead Sciences Inc's sofosbuvir drug is safe and effective when used in combination with other therapies to treat hepatitis C. Gilead Sciences Inc. (NASDAQ:GILD) is currently up (+116.09%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)